<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940126-2-00100</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments are invited and must be received on or  <!-- PJG 0012 frnewline --> before March 28, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> <!-- PJG FTAG 4717 -->  <!-- PJG STAG 4717 -->  <!-- PJG ITAG l=01 g=1 f=2 --> Wednesday <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=02 g=1 f=2 --> January 26, 1994 <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=2 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=03 g=1 f=2 --> Part II <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=04 g=1 f=2 --> Department of Health and Human Services <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=2 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=05 g=1 f=2 --> Centers for Disease Control and Prevention <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=09 g=1 f=2 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=05 g=1 f=2 --> Proposed New Vaccine Information Materials; Notice <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG -->  <!-- PJG /FTAG -->  <!-- PJG FTAG 4701 -->  <!-- PJG STAG 4701 -->  <!-- PJG ITAG l=90 g=1 f=2 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=90 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=90 g=1 f=1 --> &blank;/&blank;Vol. 59, No. 17&blank;/&blank;Wednesday, January 26, 1994&blank;/&blank; Notices <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG -->  <!-- PJG /FTAG -->  <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Centers for Disease Control and Prevention <!-- PJG /ITAG -->  <!-- PJG /STAG -->  <!-- PJG STAG 4704 --> </USBUREAU> <!-- PJG ITAG l=55 g=1 f=1 --> Proposed New Vaccine Information Materials  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG -->  <!-- PJG STAG 4703 -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Centers for Disease Control and Prevention (CDC), Public  <!-- PJG 0012 frnewline --> Health Service, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice with comment period. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  As required by Public Law 99&hyph;660, CDC developed extensive vaccine information materials for distribution by health care providers to parents prior to administration of particular vaccines to children. In response to concerns expressed regarding the length and readability of the materials and the process for development of the materials, the law was revised by Public Law 103&hyph;183 to provide for simplification of the vaccine information materials. CDC is publishing for public comment proposed new vaccine information materials which comply with the revised law. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments are invited and must be received on or  <!-- PJG 0012 frnewline --> before March 28, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </DATE> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Written comments should be addressed to Walter A. Orenstein, M.D., Director, National Immunization Program, Centers for Disease Control and Prevention, Mailstop E&hyph;05, 1600 Clifton Road, NE., Atlanta, Georgia 30333. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </ADDRESS> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Walter A. Orenstein, M.D., Director, National Immunization Program, Centers for Disease Control and Prevention, Mailstop E&hyph;05, 1600 Clifton Road, NE., Atlanta, Georgia 30333, (404) 639&hyph;8200. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Title III of Public Law 99&hyph;660 (the National Childhood Vaccine Injury Act of 1986) added a new Title XXI to the Public Health Service Act. Section 2126 of the Public Health Service Act (42 U.S.C. 300aa&hyph;26) required the Secretary of Health and Human Services to develop by rule extensive vaccine information materials for distribution by health care providers to the legal representatives of any child receiving particular vaccines (i.e., diphtheria, tetanus, pertussis, measles, mumps, rubella, and poliomyelitis vaccines). These vaccine information materials were developed as required by section 2126 of the Public Health Service Act and were issued as a final rule on October 15, 1991 (56 FR 51798; codified at 42 CFR part 110). Since April 15, 1992, any health care provider who intends to  <!-- PJG 0012 frnewline --> administer one of the covered vaccines is required to provide copies of vaccine information materials that comply with the requirements of section 2126 prior to administration of these vaccines.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Based on concerns expressed by providers and others concerning the length and readability of the vaccine information materials (each of the three existing vaccine information pamphlets is 10 pages long) and the lengthy development and revision process required by the rulemaking process (development of the materials took approximately three years), the Department proposed legislation to amend section 2126 to provide for simplification of the vaccine information materials. Congress in section 708 of Public Law 103&hyph;183, which was enacted on December 14, 1993, revised section 2126 to: (1) Delete the requirement for development and revision of the vaccine information materials by rulemaking; (2) simplify the information to be included in the materials; and (3) clarify that the materials must not only be provided to the parent or legal representative of a child receiving a covered vaccine, but also must be provided to any adult who receives a covered vaccine.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Section 2126, as amended by Public Law 103&hyph;183, requires that information contained in the materials be based on available data and information, be presented in understandable terms, and include:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <!-- PJG /STAG --></p>
		</main>
</body></html>
            